“…Contralateral suppression of OAEs is typically used to assess MOC activity, wherein OAEs are measured without and with contralateral acoustic stimulation (CAS) that activates the contralateral MOC pathway. Contralateral suppression has been described for all types of OAEs, including spontaneous otoacoustic emissions (SOAEs) (e.g., Mott et al, 1989;Zhao and Dhar, 2010), stimulus frequency otoacoustic emissions (SFOAEs) (e.g., Guinan et al, 2003;Lilaonitkul and Guinan, 2009;Zhao et al, 2015), distortion-product otoacoustic emissions (DPOAEs) (e.g., Siegel and Kim, 1982;Moulin et al, 1993;Abdala et al, 2009;Deeter et al, 2009), and transient-evoked otoacoustic emissions (TEOAEs) (e.g., Collet et al, 1990;Hood et al, 1996;Mertes and Goodman, 2016). Unlike DPOAEs, which are generated in the cochlea by two mechanisms, TEOAEs elicited by low to moderate stimulus levels are generated by only one cochlear mechanism (Shera and Guinan, 1999), which simplifies the interpretation of the TEOAE magnitude changes observed in the presence of CAS.…”